Literature DB >> 15099292

Rituximab in patients with refractory thrombotic thrombocytopenic purpura.

S Sallah, A Husain, J Y Wan, N P Nguyen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15099292     DOI： 10.1111/j.1538-7836.2004.00678.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.

Authors:  Domenica Caramazza; Gerlando Quintini; Ignazio Abbene; Lucio Lo Coco; Alessandra Malato; Rosa Di Trapani; Giorgia Saccullo; Giuseppina Pizzo; Roberto Palazzolo; Rita Barone; Giuseppina Mazzola; Sergio Rizzo; Paolo Ragonese; Paolo Aridon; Vincenzo Abbadessa; Sergio Siragusa
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Treatment of thrombotic thrombocytopenic purpura.

Authors:  Menno van der Straaten; Sophie Jamart; Robert Wens; Philippe Gottignies; Max Dratwa; Jacques Devriendt
Journal:  Intensive Care Med       Date:  2005-02-10       Impact factor: 17.440

3.  [Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination].

Authors:  Regina Hermann; Alexander Pfeil; Martin Busch; Christiane Kettner; Daniel Kretzschmar; Andreas Hansch; Paul La Rosée; Gunter Wolf
Journal:  Med Klin (Munich)       Date:  2010-09-28

Review 4.  Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors:  Nay M Tun; Gina M Villani
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 5.  How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.

Authors:  Marie Scully; Tim Goodship
Journal:  Br J Haematol       Date:  2014-01-06       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.